← Back to patent-cliff list
CAS 1388803-90-4
Benzoic acid, 2-chloro-6-methyl-, 2-[4-methyl-3-[2-(3-quinolinyl)ethynyl]benzoyl]hydrazide
Codes: SUN-K706
Application context (from source-drug indications)
Chronic myeloid leukaemiaVodobatinibLewy body dementiaVodobatinibMyeloid leukaemiaVodobatinibParkinson's diseaseVodobatinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Vodobatinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
methyl 3-iodo-4-methylbenzoate→methyl 4-methyl-3-((trimethylsilyl)ethynyl)benzoate→methyl 3-ethynyl-4-methylbenzoate→3-iodoquinoline→methyl 4-methyl-3-(quinolin-3-ylethynyl)benzoate→4-methyl-3-(quinolin-3-ylethynyl)benzoic acid→2-chloro-6-methylbenzohydrazide→Benzoic acid, 2-chloro-6-methyl-, 2-[4-methyl-3-[2-(3-quinolinyl)ethynyl]benzoyl]hydrazide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.